Why Xeris Pharmaceuticals Shares Traded Higher Today
Xeris Pharmaceuticals Inc (NASDAQ: XERS) is trading significantly higher Monday after the company announced U.S. Food and Drug Administration approval of its New Drug Application for Gvoke for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes two yea
